ESOC 2023 | Implementing ICH care bundles in low- and middle-income countries: insights from INTERACT3

Menglu Ouyang, PhD, MPH, BN, The George Institute for Global Health, University of New South Wales, Sydney, Australia, discusses the challenges of implementing changes to improve stroke outcomes in low- and middle-income countries. The recent INTERACT3 clinical trial demonstrated the effectiveness, feasibility, and acceptability of a goal-directed care bundle protocol for acute intracerebral hemorrhage (ICH). While the trial provided conclusive evidence in support of active management of ICH, its use was only tested in Chinese institutions. Dr Ouyang believes the findings of INTERACT3 are applicable to other countries, as most interventions were basic physiological monitoring and management rather than complex surgical treatment. The introduction of a care bundle for intracerebral hemorrhage doesn’t need additional devices, however monitoring equipment and staff training would be required. Challenges within low- and middle-income countries include issues with resources, insufficient medical equipment, and staffing difficulties. Therefore, these factors need to be considered when implementing changes in low- and middle- income countries. This interview took place during the European Stroke Organisation Conference (ESOC) in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.